Knöchelödeme—Nicht Alle Dihydropyridin-Kalziumantagonisten Sind Gleich Beschaffen †
Summary
Inzidenz
Pathogenese
Klinische Studien
Schlussfolgerungen
Conflicts of Interest
References
- Leonetti, G.; Magnani, B.; Pessina, A.C.; Rappelli, A.; Trimarco, B.; Zanchetti, A.; on behalf of the COHORT Study Group. Tolerability of long-term treatment with lercanidipine vs. amlodipine and lacidipine in elderly hypertensives. Am J Hypertens. in press.
- Messerli, F.H.; Feng, Z. Vasodilatory edema: synergistic effect of highdose calcium antagonist/ACE inhibitor combination therapy (Abstract). Am J Hypertens. 1999, 12, 121A. [Google Scholar] [CrossRef]
- Messerli, F.H.; Oparil, S.; Feng, Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000, 86, 1182–1187. [Google Scholar] [CrossRef] [PubMed]
- Borghi, C.; Prandin, M.G.; Dormi, A.; Ambrosioni, E.; Study Group of the Regional Unit of the Italian Society of Hypertension. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Press Suppl. 2003, 12 (Suppl. S1), 14–21. [Google Scholar] [CrossRef] [PubMed]
- Burnier, M.; Gasser, U.E. Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice. Expert Opin Pharmacother. 2007, 8, 2215–2223. [Google Scholar] [CrossRef] [PubMed]
- Lund-Johansen, P.; Stranden, E.; Helberg, S.; Wessel-Aas, T.; Risberg, K.; Ronnevik, P.K.; et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens. 2003, 21, 1003–1010. [Google Scholar] [CrossRef] [PubMed]
- Epstein, M. Natriuretic effect. Cardiovasc Drug Rev. 1991, 9, 399–413. [Google Scholar]
- Weir, M.R.; Rosenberger, C.; Fink, J.C. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens. 2001, 14, 963–968. [Google Scholar] [CrossRef] [PubMed]
- Pedrinelli, R.; Dell’Omo, G.; Mariani, M. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension. J Hum Hypertens. 2001, 15, 455–461. [Google Scholar] [CrossRef] [PubMed]
- Sabbatini, M.; Leonardi, A.; Testa, R.; Vitaioli, L.; Amenta, F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000, 35, 775–779. [Google Scholar] [CrossRef] [PubMed]
- Fogari, R.; Malamani, G.D.; Zoppi, A.; et al. Comparative Effect of Lercanidipine and Nifedipine Gastrointestinal Therapeutic System on Ankle Volume and Subcutaneous Interstitial Pressure in Hypertensive Patients: A Double-Blind, randomized, Parallel-Group Study. Curr Ther Res. 2000, 61, 850–861. [Google Scholar] [CrossRef]
- Leonetti, G.; Magnani, B.; Pessina, A.C.; et al. Tolerability of Long-Term Treatment With Lercanidipine Versus Amlodipine and Lacidipine in Elderly Hypertensive. Am J Hypertens. 2002, 15, 932–940. [Google Scholar] [CrossRef] [PubMed]
- Cherubini, A.; Fabris, F.; Ferrari, E.; et al. Comparative effects of lercanidipine, lacidipine and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the Elderly and Lercanidipine (ELLE) study. Arch Gerentol Geriatr. 2003, 37, 203–212. [Google Scholar] [CrossRef] [PubMed]
- Pedrinelli, R.; Dell’Olmo, G.; Nuti, M.; et al. Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens. 2003, 21, 1969–1973. [Google Scholar] [CrossRef] [PubMed]
- Cafiero, M.; Giasi, M. Long Term (12-Month) Treatment with Lercanidipine in Patients with Mild to Moderate Hypertension. J Cardiovasc Pharmacol. 1997, 29 (Suppl. 2), 45–49. [Google Scholar] [CrossRef]
- Barrios, V.; Navarro, A.; Esteres, A.; et al. Antihypertensive Efficacy and Tolerability of Lercanidipine in Daily Clinical Practice. The ELYPSE Study. Blood Press. 2002, 11, 95–100. [Google Scholar] [CrossRef] [PubMed]
- Schwinger, R.H.; Schmidt-Mertens, A. The new lipophilic calcium channel blocker Lercanidipine combines high antihypertensive efficacy with low side effects. Dtsch Med. Wochenschr. 2002, 127 (Suppl 1), 13. [Google Scholar]
- Allaert, F.A.; Scart-Gres, C.; Bassous, M.; et al. Efficacité, tolérance et observance de Zanidip® (Lercanidipine) dans le traitement de l’hypertension artérielle essentielle en pratique quotidienne de médecine générale. Angéioloige 2003, 55, 1–8. [Google Scholar]
- Barrios, V.; Calderon, A.; Navarro, A.; et al. Lercanidipine in an Effective and Well Tolerated Drug in Essential Hypertension, Independently of the Cardiovascular Risk. The LAURA study. J Hypertens 2004, 22 (Suppl. 2). Poster P2.295 14th European Meeting of Hypertension, Paris, France. [Google Scholar] [CrossRef]
© 2009 by the author. Attribution - Non-Commercial - NoDerivatives 4.0
Share and Cite
Messerli, F.H.; Grossman, E. Knöchelödeme—Nicht Alle Dihydropyridin-Kalziumantagonisten Sind Gleich Beschaffen. Cardiovasc. Med. 2009, 12, 301. https://doi.org/10.4414/cvm.2009.01461
Messerli FH, Grossman E. Knöchelödeme—Nicht Alle Dihydropyridin-Kalziumantagonisten Sind Gleich Beschaffen. Cardiovascular Medicine. 2009; 12(11):301. https://doi.org/10.4414/cvm.2009.01461
Chicago/Turabian StyleMesserli, Franz H., and Ehud Grossman. 2009. "Knöchelödeme—Nicht Alle Dihydropyridin-Kalziumantagonisten Sind Gleich Beschaffen" Cardiovascular Medicine 12, no. 11: 301. https://doi.org/10.4414/cvm.2009.01461
APA StyleMesserli, F. H., & Grossman, E. (2009). Knöchelödeme—Nicht Alle Dihydropyridin-Kalziumantagonisten Sind Gleich Beschaffen. Cardiovascular Medicine, 12(11), 301. https://doi.org/10.4414/cvm.2009.01461